相关实验视频

Updated: Mar 18, 2026

Kidney Regeneration in Adult Zebrafish by Gentamicin Induced Injury

Kidney Regeneration in Adult Zebrafish by Gentamicin Induced Injury

Published on: August 3, 2015

勒卡尼迪平对抗 gentamicin 诱导的脏损伤的脏保护作用

Maryam H Shubbar¹, Hussam H Kadhum¹

¹Department of Pharmacology and Toxicology, Pharmacy College, Al Farabi University, Baghdad, Iraq.

Journal of advanced pharmaceutical technology & research

|March 16, 2026

概括

勒卡尼迪平是一种通道阻塞剂,通过减少氧化应激和恢复电解质平衡,保护免受 جنت米辛诱导的损伤. 这项对大鼠的研究表明,勒卡尼迪平增强了抗氧化防御,改善了功能.

科学领域:

药理学药理学是指药理学的学科.
腎臟病學 (nephrology) 是一種醫學專業.
毒理学毒理学毒理学

背景情况:

众所周知,Gentamicin是一种aminoglycoside抗生素,主要通过氧化应激引起毒性.
了解胺诱导的损伤机制对于制定有效的保护策略至关重要.

研究的目的:

在大鼠模型中,评估勒卡尼迪平,一种通道阻塞剂,对 gentamicin 诱导的损伤的脏保护作用.
研究勒卡尼迪平对氧化应激标志物和功能参数的影响.

主要方法:

成年斯普拉格-道利大鼠被分为对照组,勒卡尼迪平,珍塔米辛和组合治疗组.
通过测量血清尿素,肌素,电解质 (Na +,K +) 和尿液体积来评估功能.
分析了同质的氧化应激标志物:甲 (MDA),谷氨酸 (GSH) 和超氧化物失调酶 (SOD) 的活性.

主要成果:

亨塔米辛的使用导致显著的功能障碍,其特征是尿素和肌素的升高,改变了Na+和K+水平,并减少了尿液输出.
勒卡尼迪平的联合治疗显著改善了功能,恢复了电解质平衡 (Na +,K +) 和增加了尿液体积,相比单独使用 جنت米辛.
勒卡尼迪平通过降低MDA水平并增加SOD和GSH活动显著减轻了根他米辛诱导的氧化应激.

结论:

勒卡尼迪平在老鼠中表现出显著的脏保护潜力,可以防止 gentamicin 诱导的脏损伤.
保护机制包括改善功能,使电解质平衡正常化,并加强抗氧化剂防御系统.
勒卡尼迪平代表了一种有前途的治疗药物,可以缓解与珍塔素相关的毒性.

关键词:

这是一种 gentamicin.造成脏损伤的情况.莱尔卡尼迪皮因 (Lercanidipine) 是一种这是一种神经保护性药物.毒性毒性毒性

更多相关视频

Laser Ablation of the Zebrafish Pronephros to Study Renal Epithelial Regeneration

Laser Ablation of the Zebrafish Pronephros to Study Renal Epithelial Regeneration

Published on: August 29, 2011

Intravenous Microinjections of Zebrafish Larvae to Study Acute Kidney Injury

Intravenous Microinjections of Zebrafish Larvae to Study Acute Kidney Injury

Published on: August 4, 2010

相关概念视频

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...

Renal Failure: Dose Adjustments

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...